MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6406-1586-1590$20.00
Mol Pharmacol 64:1586-1590, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berry, E. B. E.
Right arrow Articles by Marvin, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berry, E. B. E.
Right arrow Articles by Marvin, K. W.

Peroxisome Proliferator-Activated Receptor Isoform Expression Changes in Human Gestational Tissues with Labor at Term

Elicia B. E. Berry, Roberta Eykholt, Rachel J. A. Helliwell, R. Stewart Gilmour, Murray D. Mitchell, and Keith W. Marvin

Faculty of Medical and Health Sciences, The Liggins Institute, University of Auckland, Auckland, New Zealand

Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear receptors that are involved in lipid metabolism, differentiation, proliferation, cell death, and inflammation. Three subtypes have been identified: PPAR-{alpha}, -{delta}, and -{gamma}. We have previously shown presence of PPAR-{gamma} mRNA in the amnion, choriodecidua, and placenta, and its level of expression was unchanged with labor. To evaluate whether PPAR-{alpha} and -{delta} subtypes are present in intrauterine tissues, placentae were obtained from women at term after spontaneous vaginal delivery (TSL; n = 15) and elective caesarean section before labor (TNL; n = 15). Northern blot analyses were used to evaluate the mRNA for PPARs. Activities of PPARs were assessed using JEG3 choriocarcinoma cells transfected with a PPAR-response element reporter construct (pTK-PPREx3-luc) and treated with PPAR ligands. The PPAR-{gamma}-specific ligand rosiglitazone induced PPAR response element (PPRE)-mediated activity in a concentration-dependent manner, whereas the PPAR-{gamma}-specific irreversible inhibitor GW9662 fully inhibited this induction. However, GW9662 only partially inhibited 15-deoxy-{Delta}12,14-prostaglandin J2 (15d-PGJ2)-induced luciferase activity, suggesting that 15d-PGJ2 may also activate either of the other isoforms. PPAR-{alpha} and -{delta} are expressed in the amnion, choriodecidua, and placental villous tissues. In the amnion, although for PPAR-{alpha} no significant difference in expression was observed with labor, PPAR-{delta} expression increased significantly (p < 0.001). In the choriodecidua, expression of PPAR-{alpha} declined with labor (p < 0.01), whereas, as in the amnion, PPAR-{delta} expression increased (p < 0.05). In the placenta, both PPAR-{alpha} and -{delta} expression increased with labor (p < 0.005). The changes observed with labor suggest that regulation of PPAR expression and function may have roles to the mechanisms that maintain pregnancy or initiate labor.


Received June 2, 2003; accepted September 17, 2003

Address correspondence to: Elicia Berry, The Liggins Institute, University of Auckland, Private Bag 92019, Auckland, New Zealand. E-mail: ebe.berry{at}auckland.ac.nz




This article has been cited by other articles:


Home page
Toxicol SciHome page
D. E. Keil, T. Mehlmann, L. Butterworth, and M. M. Peden-Adams
Gestational Exposure to Perfluorooctane Sulfonate Suppresses Immune Function in B6C3F1 Mice
Toxicol. Sci., May 1, 2008; 103(1): 77 - 85.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. L. Takacs and B. D. Abbott
Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors ({alpha}, {beta}/{delta}, {gamma}) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate
Toxicol. Sci., January 1, 2007; 95(1): 108 - 117.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P Froment, F Gizard, D Defever, B Staels, J Dupont, and P Monget
Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition.
J. Endocrinol., May 1, 2006; 189(2): 199 - 209.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. J. A. Helliwell, J. A. Keelan, K. W. Marvin, L. Adams, M. C. Chang, A. Anand, T. A. Sato, S. O'Carroll, T. Chaiworapongsa, R. J. Romero, et al.
Gestational Age-Dependent Up-Regulation of Prostaglandin D Synthase (PGDS) and Production of PGDS-Derived Antiinflammatory Prostaglandins in Human Placenta
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 597 - 606.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. B. E. Berry, J. A. Keelan, R. J. A. Helliwell, R. S. Gilmour, and M. D. Mitchell
Nanomolar and Micromolar Effects of 15-Deoxy-{Delta}12,14-prostaglandin J2 on Amnion-Derived WISH Epithelial Cells: Differential Roles of Peroxisome Proliferator-Activated Receptors {gamma} and {delta} and Nuclear Factor {kappa}B
Mol. Pharmacol., July 1, 2005; 68(1): 169 - 178.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. M Lindstrom and P. R Bennett
15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits Interleukin-1{beta}-Induced Nuclear Factor-{kappa}B in Human Amnion and Myometrial Cells: Mechanisms and Implications
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3534 - 3543.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics